In addition, LSD1 inhibitors can sensitize SCLC cells to anti–PD-L1 blockade and have shown an additive antiproliferative effect when combined with YAP inhibitors in oral squamous cell carcinoma cells (122, 123). This evidence concerns the gene YAP1 and small cell lung carcinoma.